109 related articles for article (PubMed ID: 9083492)
1. Sulfonimidamide analogs of oncolytic sulfonylureas.
Toth JE; Grindey GB; Ehlhardt WJ; Ray JE; Boder GB; Bewley JR; Klingerman KK; Gates SB; Rinzel SM; Schultz RM; Weir LC; Worzalla JF
J Med Chem; 1997 Mar; 40(6):1018-25. PubMed ID: 9083492
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor evaluation of benzoylphenylurea analogs.
Gurulingappa H; Amador ML; Zhao M; Rudek MA; Hidalgo M; Khan SR
Bioorg Med Chem Lett; 2004 May; 14(9):2213-6. PubMed ID: 15081011
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems.
Rostom SA
Bioorg Med Chem; 2006 Oct; 14(19):6475-85. PubMed ID: 16806944
[TBL] [Abstract][Full Text] [Related]
4. Effect of albumin on antitumor activity of diarylsulfonylureas.
Schultz RM; Andis SL; Toth JE; Boder GB; Rinzel SM; Grindey GB
Anticancer Res; 1993; 13(6A):1939-43. PubMed ID: 8297099
[TBL] [Abstract][Full Text] [Related]
5. Novel diarylsulfonylurea derivatives as potent antimitotic agents.
Kim S; Park JH; Koo SY; Kim JI; Kim MH; Kim JE; Jo K; Choi HG; Lee SB; Jung SH
Bioorg Med Chem Lett; 2004 Dec; 14(24):6075-8. PubMed ID: 15546733
[TBL] [Abstract][Full Text] [Related]
6. Sulfonylureas: a new class of cancer chemotherapeutic agents.
Mohamadi F; Spees MM; Grindey GB
J Med Chem; 1992 Aug; 35(16):3012-6. PubMed ID: 1501228
[TBL] [Abstract][Full Text] [Related]
7. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of levan polysaccharides from selected microorganisms.
Yoo SH; Yoon EJ; Cha J; Lee HG
Int J Biol Macromol; 2004 Apr; 34(1-2):37-41. PubMed ID: 15178007
[TBL] [Abstract][Full Text] [Related]
10. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells.
Alonso MM; Encío I; Martínez-Merino V; Gil M; Migliaccio M
Br J Cancer; 2001 Nov; 85(9):1400-2. PubMed ID: 11720481
[TBL] [Abstract][Full Text] [Related]
11. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.
Abdel-Aziz AA; El-Azab AS; El-Subbagh HI; Al-Obaid AM; Alanazi AM; Al-Omar MA
Bioorg Med Chem Lett; 2012 Mar; 22(5):2008-14. PubMed ID: 22318157
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents.
Song DQ; Du NN; Wang YM; He WY; Jiang EZ; Cheng SX; Wang YX; Li YH; Wang YP; Li X; Jiang JD
Bioorg Med Chem; 2009 Jun; 17(11):3873-8. PubMed ID: 19410466
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
17. Bombesin analogs containing alpha-amino-isobutyric acid with potent anticancer activity.
Prasad S; Mathur A; Gupta N; Jaggi M; Singh AT; Rajendran P; Sanna VK; Datta K; Mukherjee R
J Pept Sci; 2007 Jan; 13(1):54-62. PubMed ID: 17031871
[TBL] [Abstract][Full Text] [Related]
18. Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas.
Ehlhardt WJ; Woodland JM; Worzalla JF; Bewley JR; Grindey GB; Todd GC; Toth JE; Howbert JJ
Chem Res Toxicol; 1992; 5(5):667-73. PubMed ID: 1446007
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM
J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
